Heron Therapeutics, Inc. (HRTX)
0.293
+0.01
(+4.64%)
USD |
NASDAQ |
Nov 06, 16:00
0.2859
-0.01
(-2.42%)
After-Hours: 20:00
Heron Therapeutics Total Long Term Debt (Quarterly) : 148.15M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 148.15M |
| March 31, 2026 | 141.63M |
| December 31, 2025 | 140.64M |
| September 30, 2025 | 139.66M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 174.97M |
| December 31, 2024 | 174.73M |
| September 30, 2024 | 175.00M |
| June 30, 2024 | 175.52M |
| March 31, 2024 | 176.03M |
| December 31, 2023 | 176.55M |
| September 30, 2023 | 177.00M |
| June 30, 2023 | 153.54M |
| March 31, 2023 | 154.17M |
| December 31, 2022 | 154.78M |
| September 30, 2022 | 155.38M |
| June 30, 2022 | 155.96M |
| March 31, 2022 | 156.52M |
| December 31, 2021 | 157.08M |
| September 30, 2021 | 161.25M |
| June 30, 2021 | 162.00M |
| March 31, 2021 | 13.79M |
| December 31, 2020 | 14.56M |
| September 30, 2020 | 15.30M |
| June 30, 2020 | 16.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.71M |
| December 31, 2019 | 12.24M |
| September 30, 2019 | 10.78M |
| June 30, 2019 | 11.25M |
| March 31, 2019 | 11.72M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 25.00M |
| March 31, 2018 | 25.00M |
| December 31, 2017 | 25.00M |
| September 30, 2017 | 25.00M |
| June 30, 2017 | 25.00M |
| March 31, 2017 | 53.10M |
| December 31, 2016 | 50.00M |
| September 30, 2016 | 50.00M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 1.022M |
| Karyopharm Therapeutics, Inc. | 255.12M |
| Minerva Neurosciences, Inc. | 71.74M |
| Corbus Pharmaceuticals Holdings, Inc. | 3.265M |
| Ocugen, Inc. | 4.599M |